WT1


Also found in: Medical.
AcronymDefinition
WT1Wilms Tumor 1
WT1Weapons Technician First Class (Naval Rating)
References in periodicals archive ?
Our results also showed the positivity of WT1 in each of the histological grade of OSCC suggesting the tumorigenesis role.
Although positive, WT1 is the least reliable immunostain for mesothelial cells as serous carcinomas can also express the protein [13] whereas vacuolated cells and thread-like bridges are actually characteristic and supportive of the diagnosis of adenomatoid tumors [5, 15].
21 June 2017 - London-based cellular immunotherapy developer Cell Medica has acquired UK-based Cell and Gene Therapy Catapult subsidiary Catapult Therapy TCR Ltd., a developer of the WT1 T cell receptor, initiating a collaboration for Cell Medica to manufacture cell therapy at CGT Catapult's GMP UK-based manufacturing facility, the company said.
Tari, "HER2/neu increases the expression of Wilms' Tumor 1 (WT1) protein to stimulate S-phase proliferation and inhibit apoptosis in breast cancer cells," Oncogene, vol.
WT1 is essential for urogenital development, and its expression is limited to mature podocytes [7].
As in certain other tumors, the function of the Wilms tumor protein (WT1) in repressing gene transcription is lost in DSRCT [31].
These include the transcription factor Wilms tumor-1 (WT1), which is a marker for rapidly proliferating cells and cancer stem cells (Svensson et al., 2007; Makki et al., 2008; Ruan et al., 2018; Pons et al., 2018), and p53, which is seen as the guardian of the genome (Hofseth et al., 2004).
The mutations in AML involve epigenetic modifiers (TET2, IDH1/IDH2, DNMT3A, ASXL1, KMT2A, EZH2), activated signaling pathway (FLT3, KRAS, NRAS, KIT), tumor suppressor genes (TP53, WT1), RNA splicing (SF3B1), nucleophosmin mutation (NPM1), and genes coding for transcription-differentiation (CEBPA, RUNX1) (Figure 1) (6-8).
WT1 (Wilm's tumor gene), is a transcription factor that modulates the expression of genes involved in sexual differentiation, cell proliferation and apoptosis (Hewitt et al., 1995), in embryogenesis it regulates the genitourinary system (Fernandez et al., 2009), whereas in adulthood is found also in CNS and hematopoietic tissues (Yang et al., 2007).
The WT1 was originally isolated as a tumor-suppressor gene that is inactivated in a subset of Wilms'tumor and mutated in the germline of children with genetic predisposition to this kidney neoplasm of childhood.
Intellia's proprietary ex vivo programs include its acute myeloid leukemia (AML) program utilizing transgenic T cell receptors (TCRs) against Wilms' Tumor 1 (WT1), a target identified in collaboration with Ospedale San Raffaele (OSR).
The WT1 Weight Indicator is a cost-effective DIN rail indicator with a 5-digit display that provides accurate readings, high performance, and long-term reliability.